SLIDESHOW: Top 10 Analyst Rated Healthcare Stocks
By ETF Channel Staff, updated Tue, May 20, 2:23 PM
This Slide: #2 of 10 |
#9: Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Regeneron Pharmaceuticals, Inc. is a fully integrated biotechnology company. Co. invents, develops, manufactures, and commercializes medicines for people with serious diseases. Its products and product candidates in development are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, neurological diseases, hematologic conditions, infectious diseases, and rare diseases. Open the REGN Page at ETF Channel »
![]()
![]() |
Open the ETF Channel REGN Page (in a new window) »
![]() Strong Buy (3.60 out of 4) 61st percentile
(ranked higher than approx. 61% of all stocks covered)
Based on data provided by Zacks Investment Research via Quandl.com ![]() |


![]() ![]() Get Dividend Alerts ![]() Get SEC Filing Alerts ![]() ![]() |
![]() Strong Buy (3.60 out of 4) 61st percentile
(ranked higher than approx. 61% of all stocks covered)
Analysts Forecast: REGN Price Target Based on data provided by Zacks Investment Research via Quandl.com ![]() |

![]() |